Lloyd A. Rowland, General Counsel: CytomX Therapeutics CTMX Sell · Filed 24/08/22

Trade details

Type: Insider sale
Amount: $5,142.63
Shares · price: 4,181 sh · $1.23 a share
Held after: 130,797 sh
Stock: CytomX Therapeutics CTMX
Person: Lloyd A. RowlandGeneral Counsel
Trade date: 24/08/20
Filed: 24/08/22
Days to filing: 2 days

Sold 3.1% of holdings

Share of holding sold: 3.1%

CytomX Therapeutics trades, last 26 weeks

What else happened in CytomX Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/21~24/09/19

Lloyd A. Rowland's recent trades

Lloyd A. RowlandGeneral Counsel
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$6,122
10,203 sh
$6,122
Filed 25/03/20
Traded 25/03/18
Lloyd A. RowlandGeneral Counsel
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$11K
5,268 sh
$11K
Filed 24/03/21
Traded 24/03/19
Lloyd A. RowlandGeneral Counsel
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$5,626
4,077 sh
$5,626
Filed 23/12/22
Traded 23/12/20
Lloyd A. RowlandGeneral Counsel
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$7,132
5,486 sh
$7,132
Filed 23/09/22
Traded 23/09/22
Lloyd A. RowlandGeneral Counsel
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$4,033
2,037 sh
$4,033
Filed 23/03/20
Traded 23/03/16